Linetta B. Koppert

ORCID: 0000-0003-1944-6777
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Breast Implant and Reconstruction
  • BRCA gene mutations in cancer
  • Breast Lesions and Carcinomas
  • Global Cancer Incidence and Screening
  • Cancer survivorship and care
  • Cancer Genomics and Diagnostics
  • Esophageal Cancer Research and Treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Cancer Risks and Factors
  • Genetic Associations and Epidemiology
  • Nutrition, Genetics, and Disease
  • Clinical practice guidelines implementation
  • Cancer Treatment and Pharmacology
  • Gastric Cancer Management and Outcomes
  • Family Support in Illness
  • Nonmelanoma Skin Cancer Studies
  • Economic and Financial Impacts of Cancer
  • Genetic factors in colorectal cancer
  • Cancer Diagnosis and Treatment
  • Esophageal and GI Pathology
  • HER2/EGFR in Cancer Research
  • Reconstructive Surgery and Microvascular Techniques
  • Advanced Breast Cancer Therapies
  • Cancer-related gene regulation

Erasmus MC Cancer Institute
2015-2024

Erasmus MC
2010-2024

Erasmus University Rotterdam
2012-2024

Rotterdam University of Applied Sciences
2014-2023

University Medical Center
2017-2023

University Hospital and Clinics
2017-2023

Netherlands Comprehensive Cancer Organisation
2017-2023

Wikimedia Nederland
2023

Maastricht University Medical Centre
2023

Maastricht University
2023

Yan Guo Shaneda Warren Andersen Xiao‐Ou Shu Kyriaki Michailidou Manjeet K. Bolla and 95 more Qin Wang Montserrat García‐Closas Roger L. Milne Marjanka K. Schmidt Jenny Chang‐Claude Alison M. Dunning Stig E. Bojesen Habibul Ahsan Kristiina Aittomäki Irene L. Andrulis Hoda Anton‐Culver Volker Arndt Matthias W. Beckmann Alicia Beeghly‐Fadiel Javier Benı́tez Natalia Bogdanova Bernardo Bonanni Anne‐Lise Børresen‐Dale Judith S. Brand Hiltrud Brauch Hermann Brenner Thomas Brüning Barbara Burwinkel Graham Casey Georgia Chenevix‐Trench Fergus J. Couch Angela Cox Simon S. Cross Kamila Czene Peter Devilee Thilo Dörk Martine Dumont Peter A. Fasching Jonine D. Figueroa Dieter Flesch‐Janys Olivia Fletcher Henrik Flyger Florentia Fostira Marilie D. Gammon Graham G. Giles Pascal Guénel Christopher A. Haiman Ute Hamann Maartje J. Hooning John L. Hopper Anna Jakubowska Farzana Jasmine Mark A. Jenkins Esther M. John Nichola Johnson Michael E. Jones Maria Kabisch Muhammad G. Kibriya Julia A. Knight Linetta B. Koppert Veli‐Matti Kosma Vessela N. Kristensen Loı̈c Le Marchand Eunjung Lee Jingmei Li Annika Lindblom Robert Luben Jan Lubiński Kathi Malone Graham J. Mann Sara Margolin Frederik Marmé Catriona McLean Hanne Meijers‐Heijboer Alfons Meindl Susan L. Neuhausen Heli Nevanlinna Patrick Neven Janet E. Olson José Ignacio Arias Pérez Barbara Perkins Paolo Peterlongo Kelly‐Anne Phillips Katri Pylkäs Anja Rudolph Regina M. Santella Elinor J. Sawyer Rita K. Schmutzler Caroline Seynaeve Mitul Shah Martha J. Shrubsole Melissa C. Southey Anthony J. Swerdlow Amanda E. Toland Ian Tomlinson Diana Torres Thérèse Truong Giske Ursin Rob B. van der Luijt Senno Verhoef

Observational epidemiological studies have shown that high body mass index (BMI) is associated with a reduced risk of breast cancer in premenopausal women but an increased postmenopausal women. It unclear whether this association mediated through shared genetic or environmental factors.

10.1371/journal.pmed.1002105 article EN cc-by PLoS Medicine 2016-08-23

A major challenge in value-based health care is the lack of standardized outcomes measurements, hindering optimal monitoring and comparison quality across different settings globally. The International Consortium for Health Outcomes Measurement (ICHOM) assembled a multidisciplinary international working group, comprised 26 providers patient advocates, to develop standard set patient-centered breast cancer (BC). group convened via 8 teleconferences completed follow-up survey after each...

10.1001/jamaoncol.2016.4851 article EN JAMA Oncology 2016-12-29

Data on survival of BRCA1/2-associated primary breast cancer (PBC) patients who opt for subsequent contralateral risk-reducing mastectomy (CRRM) are scarce and inconsistent. We examined the efficacy CRRM overall in mutation carriers with a history PBC. From Dutch multicentre cohort, we selected 583 BRCA-associated PBC patients, being diagnosed between 1980 2011. Over time, 242 (42%) underwent 341 (58%) remained under surveillance. Survival analyses were performed using Cox models, as...

10.1002/ijc.29032 article EN International Journal of Cancer 2014-06-20

In healthy BRCA1/2 mutation carriers, bilateral risk-reducing mastectomy (BRRM) strongly reduces the risk of developing breast cancer (BC); however, no clear survival benefit BRRM over BC surveillance has been reported yet. this Dutch multicenter cohort study, we used multivariable Cox models with as a time-dependent covariable to estimate associations between and overall BC-specific mortality rates, separately for BRCA1 BRCA2 carriers. During mean follow-up 10.3 years, 722 out 1712 (42%)...

10.1007/s10549-019-05345-2 article EN cc-by Breast Cancer Research and Treatment 2019-07-13

Purpose Surgery has curative potential in a proportion of patients with esophageal cancer, but is associated considerable perioperative risks. We aimed to develop and validate simple risk score for surgical mortality that could be applied administrative data. Patients Methods analyzed 3,592 esophagectomy from four cohorts. logistic regression analysis predict occurring within 30 days after 1,327 cancer older than 65 years age, diagnosed between 1991 1996 the linked Surveillance, Epidemiology...

10.1200/jco.2005.05.0658 article EN Journal of Clinical Oncology 2006-09-08

This large population-based study compared breast-conserving surgery with radiation therapy (BCT) mastectomy on (long-term) breast cancer-specific (BCSS) and overall survival (OS), investigated the influence of several prognostic factors. Patients primary T1-2N0-2M0 cancer, diagnosed between 1999 2012, were selected from Netherlands Cancer Registry. We 1999-2005 (long-term outcome) 2006-2012 cohort (contemporary adjuvant systemic therapy). Cause death was derived Statistics (CBS)....

10.1002/ijc.31034 article EN International Journal of Cancer 2017-09-08

Several less-invasive staging procedures have been proposed to replace axillary lymph node dissection (ALND) after neoadjuvant chemotherapy (NAC) in patients with initially clinically node-positive (cN+) breast cancer, but these may fail detect residual disease. Owing the lack of high-level evidence, it is not yet clear which procedure most optimal ALND.To determine diagnostic accuracy radioactive iodine seed placement axilla sentinel biopsy (RISAS), a targeted procedure.This was...

10.1001/jamasurg.2022.3907 article EN JAMA Surgery 2022-09-07
William P. Weber Jane Shaw Andrea L. Pusic Lynda Wyld Monica Morrow and 86 more Tari A. King Zoltán Mátrai Jörg Heil Florian Fitzal Shelley Potter Isabel T. Rubio Maria João Cardoso Oreste ­Gentilini Viviana Galimberti Virgilio Sacchini Emiel J. Rutgers John R. Benson Tanir M. Allweis Martin Haug Régis Resende Paulinelli Tibor Kovács Yves Harder Bahadır M. Gūllūoḡlu Eduardo González Andreé Faridi Elisabeth Elder Peter Dubsky Jens‐Uwe Blohmer Vesna Bjelic‐Radisic Mitchel Barry Susanne Dieroff Hay Kimberly Bowles James French Roland Reitsamer Rupert Koller Peter Schrenk Daniela Kauer-Dorner Jorge Villanova Biazús Fabrício Brenelli Jaime Letzkus Ramon Saccilotto Sarianna Joukainen Susanna Kauhanen Ulla Karhunen‐Enckell Juergen Hoffmann Ulrich Kneser Thorsten Kühn Michalis Kontos Ekaterini Christina Tampaki Moshe Carmon Tal Hadar Giuseppe Catanuto Carlos A. Garcia‐Etienne Linetta B. Koppert Pedro Gouveia Jesper Lagergren Tor Svensjö Nadia Maggi Elisabeth A. Kappos Fabienne D. Schwab Liliana Castrezana Daniel Steffens Janna Krol Christoph Tausch Andreas R. Günthert Michael Knauer Maria C. Katapodi Susanne Bucher Nik Hauser Christian Kurzeder Rosine Mucklow Pelagia G. Tsoutsou Atakan Sezer Güldeniz Karadeniz Çakmak Hasan Karanlık Patricia Fairbrother László Romics Giacomo Montagna Cı́cero de Andrade Urban Melanie Walker Silvia Formenti Guenther Gruber Frank Zimmermann Daniel R. Zwahlen Sherko Küemmel Mahmoud El‐Tamer Marie Jeanne Vrancken Peeters Orit Kaidar‐Person Michael Gnant Philip Poortmans Jana de Boniface

Demand for nipple- and skin- sparing mastectomy (NSM/SSM) with immediate breast reconstruction (BR) has increased at the same time as indications post-mastectomy radiation therapy (PMRT) have broadened. The aim of Oncoplastic Breast Consortium initiative was to address relevant questions arising this clinically challenging scenario.A large global panel oncologic, oncoplastic reconstructive surgeons, patient advocates oncologists developed recommendations clinical practice in an iterative...

10.1016/j.breast.2022.03.008 article EN The Breast 2022-03-18

A surgical resection is currently the preferred treatment for esophageal cancer if tumor considered to be resectable without evidence of distant metastases (cT1-3 N0-1 M0). high percentage irradical resections reported in studies using neoadjuvant chemotherapy followed by surgery versus alone and trials which patients are treated with alone. Improvement locoregional control chemoradiotherapy might therefore improve prognosis these patients. We previously that after weekly administrations...

10.1186/1471-2482-8-21 article EN cc-by BMC Surgery 2008-11-26

Prophylactic skin-sparing mastectomy (SSM) and nipple-sparing (NSM) both are associated with major risk reduction in women high breast cancer risk. Skin-sparing followed by nipple-areola complex (NAC) reconstruction is standard of care, but NSM increasingly being performed. Preservation the NAC may increase patient satisfaction. Therefore, we measured sensitivity after compared satisfaction as well body image SSM NSM.Women who underwent prophylactic bilateral or immediate implant between...

10.1097/sap.0000000000000366 article EN Annals of Plastic Surgery 2014-10-29

Abstract Background Major surgery for cancer has become safer, including elderly patients with co-morbidity. The aim of this study was to investigate the association between patient characteristics, resection rates and survival among oesophageal or gastric cancer. Methods prospective Dutch population-based Eindhoven Cancer Registry oesophagogastric cancers diagnosed 1995 2009 studied retrospectively characteristics Logistic regression analysis performed assess likelihood in tumour node...

10.1002/bjs.8952 article EN British journal of surgery 2012-11-06
Maya Ghoussaini Juliet D. French Kyriaki Michailidou Silje Nord Jonathan Beesley and 95 more Sander Canisus Kristine M. Hillman Susanne Kaufmann Haran Sivakumaran Mahdi Moradi Marjaneh Jason S. Lee Joe Dennis Manjeet K. Bolla Sophia Wang Ed Dicks Roger L. Milne John L. Hopper Melissa C. Southey Marjanka K. Schmidt Annegien Broeks Kenneth Muir Artitaya Lophatananon Peter A. Fasching Matthias W. Beckmann Olivia Fletcher Nichola Johnson Elinor J. Sawyer Ian Tomlinson Barbara Burwinkel Frederik Marmé Pascal Guénel Thérèse Truong Stig E. Bojesen Henrik Flyger Javier Benı́tez Anna González‐Neira M. Rosario Alonso Guillermo Pita Susan L. Neuhausen Hoda Anton‐Culver Hermann Brenner Volker Arndt Alfons Meindl Rita K. Schmutzler Hiltrud Brauch Ute Hamann Daniel C. Tessier Daniel Vincent Heli Nevanlinna Sofia Khan Keitaro Matsuo Hidemi Ito Thilo Dörk Natalia Bogdanova Annika Lindblom Sara Margolin Graham J. Mann Veli‐Matti Kosma Anna H. Wu David Van Den Berg Diether Lambrechts Giuseppe Floris Jenny Chang‐Claude Anja Rudolph Paolo Radice Monica Barile Fergus J. Couch Emily Hallberg Graham G. Giles Christopher A. Haiman Loı̈c Le Marchand Mark S. Goldberg Soo‐Hwang Teo Cheng Har Yip Anne‐Lise Børresen‐Dale Wei Zheng Qiuyin Cai Robert Winqvist Katri Pylkäs Irene L. Andrulis Peter Devilee Rob A.�E.�M. Tollenaar Montserrat García‐Closas Jonine D. Figueroa Per Hall Kamila Czene Judith S. Brand Hatef Darabi Mikael Eriksson Maartje J. Hooning Linetta B. Koppert Jingmei Li Xiao‐Ou Shu Ying Zheng Angela Cox Simon S. Cross Mitul Shah Valerie Rhenius Ji‐Yeob Choi Daehee Kang

Genome-wide association studies (GWASs) have revealed increased breast cancer risk associated with multiple genetic variants at 5p12. Here, we report the fine mapping of this locus using data from 104,660 subjects 50 case-control in Breast Cancer Association Consortium (BCAC). With for 3,365 genotyped and imputed SNPs across a 1 Mb region (positions 44,394,495–45,364,167; NCBI build 37), found evidence least three independent signals: strongest signal, consisting single SNP rs10941679, was...

10.1016/j.ajhg.2016.07.017 article EN cc-by The American Journal of Human Genetics 2016-09-15
Coming Soon ...